Zecotek Photonics Inc. announced that the National Cancer Institute, a division of the US National Institute of Health (NIH), has released positive test results conducted on Zecotek's proprietary tunable green fiber laser. Dr. William Telford, director of the National Cancer Institute Flow Cytometry Core Laboratory in Bethesda, Md., reported that Zecotek's tunable green fiber laser provides both lower noise and enhanced detection resolution over the entire tunable range of 540 to 550 nm, resulting in an improvement in data collection and an increase in analytical capability. "The test results from the National Cancer Institute show that Zecotek's tunable green fiber laser performs better than alternative lasers in an area of research that directly contributes to the advancement of bio-instrumentation," said Dr. A.F. Zerrouk, chairman and CEO of Zecotek. "Dr. Telford is a highly respected scientist, and his research is closely followed by industry as well as other leading researchers. His observations on the advantages of our tunable green fiber lasers for flow cytometry fully support the commitment and efforts we have made to bring this important technology to market." Telford presented the test results at the prestigious Congress for the International Advancement of Cytometry (CYTO), held in Seattle in early May and attended by leading researchers, practitioners and bio-instrumentation manufacturers. He noted that both Zecotek's tunable and fixed wavelength green fiber lasers are suitable for utilizing the many new fluorescent probes for various applications, including fundamental research in immunology, hematology, organ transplantation and other biomedical fields. Telford also said that tunable lasers will now make virtually any fluorochrome accessible to analysis and will provide for new types of flourochromes not currently available to research. Tunability "will become a future requirement by end users and the research community," Telford said. For more information, visit: www.zecotek.com